Retinoblastoma

Displaying 1 - 2 of 2CSV
Kim, S., Armand, J., Safonov, A., Zhang, M., Soni, R. K., Schwartz, G., McGuinness, J. E., Hibshoosh, H., Razavi, P., Kim, M., Chandarlapaty, S., & Yang, H. W. (2023). Sequential activation of E2F via Rb degradation and c-Myc drives resistance to CDK4/6 inhibitors in breast cancer. Cell Reports, 42(11), 113198. https://doi.org/10.1016/j.celrep.2023.113198
Publication Date
Shi, C., Huang, K., Soto, J., Sankaran, R., Kalia, V., Onwumere, O., Young, M., Einbond, L., & Redenti, S. (2023). Piperlongumine inhibits proliferation and oncogenic MYCN expression in chemoresistant metastatic retinoblastoma cells directly and through extracellular vesicles. Biomedicine & Pharmacotherapy, 161, 114554. https://doi.org/10.1016/j.biopha.2023.114554
Publication Date